U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247292) titled 'Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia' on Nov. 18.
Brief Summary: This is a multi-centre, retrospective-prospective, single-arm, non-interventional (observational) cohort study with secondary data collection within real-world settings of participants with AQP4-IgG positive NMOSD.
Study Start Date: Dec. 31
Study Type: OBSERVATIONAL
Condition:
Rare Diseases
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....